August 29 (SeeNews) - The consolidated net profit of Bulgarian drug maker Sopharma [BUL:3JR] fell to 20.7 million levs ($12.3 million/10.6 million euro) in the first half of 2018 from 28.9 million levs in the same period of last year, despite a rise in revenue, the company said on Wednesday.